U.S. Forensic Genomics Market Report and Forecast 2026-2034

Study Period

2021-2034

Market (2026)

USD 0.36 Billion

Market (2034)

USD 1.07 Billion

CAGR

14.60%

Major Markets Players

Illumina Inc., Thermo Fisher , Scientific Inc., Promega Corporation, QIAGEN and Others

*Note: Partial List Randomly Ordered

U.S. Forensic Genomics Market Key Takeaways

U.S. Forensic Genomics Market Insights & Analysis

The U.S. Forensic Genomics Market is anticipated to register a 14.60% CAGR during 2026–2034. The market size was valued at USD 0.36 billion in 2026 and is projected to reach USD 1.07 billion by 2034. Sustained growth is being driven by expanding federal DNA database initiatives, increasing adoption of next-generation sequencing platforms across forensic laboratories, and growing judicial recognition of genomic evidence. The Department of Justice has continued to allocate significant funding toward forensic science capacity enhancement, with the Paul Coverdell Forensic Science Improvement Grants program supporting laboratory modernization efforts across states.

Broader adoption of investigative genetic genealogy across law enforcement agencies has transformed the operational scope of forensic genomics beyond traditional STR profiling. Public-sector investments in CODIS database expansion, combined with state-level legislative frameworks supporting familial DNA searches, are reinforcing demand for advanced sequencing instruments and interpretive software. Private forensic laboratories are also scaling capabilities in kinship analysis and disaster victim identification, supporting a diversified revenue base that extends well beyond criminal casework into civil and humanitarian applications.

U.S. Forensic Genomics Market Dynamics

The U.S. Forensic Genomics Market is gaining momentum as law enforcement agencies, forensic service providers, and academic institutions expand their genomic analytical capabilities. Rising demand for high-throughput DNA analysis, decreasing sequencing costs, and growing legislative support for expanded DNA collection and databasing are collectively accelerating market development. Advances in portable sequencing technologies and cloud-based forensic data management are further reshaping operational workflows.

Key Market Driver: Federal DNA Database Modernization Initiatives

Ongoing expansion of the Combined DNA Index System and increased federal grant disbursements to state forensic labs are directly accelerating instrument procurement and reagent consumption. The FBI's National DNA Index System processed over 21 million offender profiles as of recent reporting periods, creating sustained demand for high-throughput genotyping consumables and laboratory information management systems. Grants distributed through DOJ forensic science programs incentivize upgrades to next-generation forensic sequencing infrastructure, reinforcing long-term investment cycles across both public and private laboratory networks.

Major Industry Challenge: Jurisdictional Inconsistency in Genealogy Regulations

The absence of a unified federal regulatory framework governing investigative genetic genealogy has created significant operational uncertainty for forensic service providers. While some states have enacted clear statutory guidelines permitting controlled genealogical DNA searches, others have imposed moratoriums or outright bans, fragmenting market access for vendors offering these services. Laboratories operating across state boundaries face compliance complexity that increases operational costs and limits scalable deployment of genealogy-based workflows, constraining the near-term revenue potential of what is otherwise one of the market's highest-growth application segments.

Emerging Trend Shaping Outlook: Field-Deployable Rapid DNA Analysis

Rapid DNA platforms capable of generating CODIS-compatible profiles within two hours are being adopted by booking facilities, military installations, and border security agencies. The FBI's Rapid DNA Program has certified select instruments for direct upload to the National DNA Index System, reducing reliance on centralized laboratory workflows and enabling real-time investigative decisions. Growing federal procurement of portable sequencing units and integration of these platforms into mass disaster response protocols are broadening the addressable market for forensic genomics beyond conventional laboratory environments.

U.S. Forensic Genomics Market Segment-wise Analysis

The U.S. Forensic Genomics Market spans a wide range of application verticals and end-user categories, reflecting the technology's expanding role across criminal justice, humanitarian identification, and civil proceedings. Vendors offering integrated workflows - from DNA extraction through data interpretation - are increasingly well-positioned to capture multi-segment demand across public and private sector clients.

By Application

• Criminal Investigation
• Investigative Genetic Genealogy
• Paternity & Kinship Testing
• Disaster Victim Identification

Criminal investigation accounts for an estimated 48% of total application revenue, driven by consistent law enforcement demand for STR profiling, touch DNA analysis, and database matching across federal, state, and local agencies. This segment benefits from mandatory DNA collection laws for felony offenders in all 50 states, continuous CODIS upload requirements, and growing judicial standards that incentivize high-confidence genomic evidence. Capital investments in automated DNA processing equipment within government labs further anchor this segment's revenue share.

Investigative genetic genealogy is the fastest-growing application, gaining traction following high-profile case resolutions and increasing adoption by cold case units. This technique, which combines long-read sequencing with genealogical database cross-referencing, now supports active investigative pipelines across dozens of state agencies. Paternity and kinship testing maintains steady commercial demand through family courts and immigration proceedings, while disaster victim identification capabilities across mass casualty events are expanding through INTERPOL-aligned protocols and mitochondrial DNA reference matching.

By End-User

• Law Enforcement & Government Labs
• Private Forensic Laboratories
• Academic & Research Institutes

Law enforcement and government laboratories represent the dominant end-user segment with approximately 56% of total market revenue, reflecting their role as the primary operational consumers of forensic DNA technologies. These institutions are bound by federal and state submission mandates, creating predictable, recurring demand for genotyping reagents, sequencing instruments, and database integration software. Dedicated federal budget allocations through agencies such as the FBI, DHS, and DOD sustain long-term procurement cycles independent of broader economic fluctuations.

Private forensic laboratories account for a growing share of the market as outsourced forensic services gain acceptance among jurisdictions seeking to reduce backlogs. These labs are increasingly offering forensic kinship and genealogy testing services under contract to state crime labs, enabling faster case turnaround without proportional public investment in infrastructure. Academic and research institutes, while holding a smaller revenue share, play a critical enabling role by developing validated analytical methods, reference population datasets, and novel biomarker panels that subsequently transition into operational workflows.

Regional Projection of U.S. Forensic Genomics Market

The U.S. Forensic Genomics Market exhibits meaningful regional differentiation based on state-level legislative environments, laboratory infrastructure maturity, law enforcement budgets, and the density of forensic service providers. Federal funding distribution also influences regional capacity, with certain states receiving disproportionately higher Paul Coverdell grant allocations tied to case backlog levels and laboratory accreditation status.

• South: The South holds the largest regional revenue share at approximately 30%, driven by its extensive law enforcement infrastructure and consistently high CODIS submission volumes across Texas, Florida, Georgia, and North Carolina. Several southern states have broadened DNA collection mandates to include misdemeanor offenders, expanding the volume of samples processed annually.
• West: The West is the fastest-growing regional market, led by California's progressive adoption of investigative genetic genealogy and early integration of Rapid DNA booking systems. Washington and Oregon have established structured genealogy search policies, attracting private forensic service providers to the region and supporting above-average technology adoption rates.
• Midwest: The Midwest benefits from a dense network of state crime laboratories and strong university-industry research partnerships, particularly across Illinois, Ohio, and Michigan. Cold case reinvestigation units in these states are increasingly deploying long-read sequencing platforms to reprocess legacy biological evidence.
• Northeast: The Northeast hosts a high concentration of private forensic laboratories and world-class academic genomics programs, particularly in Massachusetts, New York, and Pennsylvania. Outsourcing of forensic DNA analysis by municipal crime labs to accredited private providers is an accelerating trend, supporting growth among commercial market participants.

U.S. Forensic Genomics Market: Recent Development (2025)

• Illumina launched an enhanced forensic sequencing panel supporting investigative genetic genealogy workflows across certified labs.
• Thermo Fisher Scientific expanded its RapidHIT ID platform with upgraded consumables targeting U.S. law enforcement booking facilities.
• Promega Corporation entered a supply agreement with a major federal agency for forensic STR genotyping reagent kits.
• QIAGEN introduced an automated DNA extraction solution validated for low-template touch DNA forensic applications nationwide.

U.S. Forensic Genomics Market Future Outlook (2034)

The U.S. Forensic Genomics Market is projected to expand at a 14.60% CAGR, reaching approximately USD 1.07 billion by 2034. Growth will be shaped by continued federal investment in DNA database modernization, broader legislative authorization of investigative genetic genealogy, and accelerating integration of next-generation sequencing into routine casework. Advances in single-cell genomics, phenotypic prediction from DNA, and AI-assisted genealogical search algorithms will expand the evidentiary value of biological evidence and open new application pathways across civil, criminal, and humanitarian identification sectors.

Long-term market expansion will be supported by increasing adoption of cloud-based laboratory information management systems, automated evidence tracking platforms, and population reference databases that improve the statistical power of forensic DNA interpretations. As instrument costs continue declining and portable sequencing solutions mature, forensic genomics capabilities will extend beyond centralized crime labs into field environments, military applications, and international disaster response operations. Vendors offering end-to-end integrated workflows - from sample collection through courtroom-ready reporting - will be best positioned to capture the full scope of this expanding market opportunity.

U.S. Forensic Genomics Market Report Coverage

Why Choose This Report?

• Comprehensive analysis covering all forensic genomics application segments and end-users.
• Accurate market sizing with a reliable forecast through 2034.
• Detailed regional breakdown across all four major U.S. geographic zones.
• Insight into federal funding programs shaping laboratory procurement decisions.
• Competitive profiling of leading forensic genomics vendors and their recent developments.
• Analysis of investigative genetic genealogy regulatory landscape and market impact.
• Data-driven research aligned with current law enforcement and judicial trends.
• Strategic insights supporting investment, product development, and go-to-market planning.